on May 21, 2007
Published online before print May 21, 2007, doi: 10.1161/CIRCULATIONAHA.107.183679
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on ,
Abstract--Atherosclerotic cardiovascular disease (CVD) is a major health problem in the United States and around the world. Evidence accumulated over decades convincingly demonstrates that family history in a parent or a sibling is associated with atherosclerotic CVD, manifested as coronary heart disease, stroke, and/or peripheral arterial disease. Although there are several mendelian disorders that contribute to CVD, most common forms of CVD are believed to be multifactorial and to result from many genes, each with a relatively small effect working alone or in combination with modifier genes and/or environmental factors. The identification and the characterization of these genes and their modifiers would enhance prediction of CVD risk and improve prevention, treatment, and quality of care. This scientific statement describes the approaches researchers are using to advance understanding of the genetic basis of CVD and details the current state of knowledge regarding the genetics of myocardial infarction, atherosclerotic CVD, hypercholesterolemia, and hypertension. Current areas of interest and investigation--including gene-environment interaction, pharmacogenetics, and genetic counseling--are also discussed. The statement concludes with a list of specific recommendations intended to help incorporate usable knowledge into current clinical and public health practice, foster and guide future research, and prepare both researchers and practitioners for the changes likely to occur as molecular genetics moves from the laboratory to clinic.
Accepted on ,
Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease. A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group
Donna K. Arnett PhD, FAHA, Chair,
This article has been cited by other articles:
 |
|
 |
|
  American College of Cardiology Foundation, American Heart Association, American College of Physicians Task Force on Compe, American Academy of Neurology, American Association of Cardiovascular and Pulmona, American College of Preventive Medicine, American Diabetes Association, American Society of Hypertension, Association of Black Cardiologists, National Lipid Association, et al. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease. J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1336 - 1363. [Full Text] [PDF]
|
|
|
|
 |
|
 WRITING COMMITTEE MEMBERS, C. N. Bairey Merz, M. J. Alberts, G. J. Balady, C. M. Ballantyne, K. Berra, H. R. Black, R. S. Blumenthal, M. H. Davidson, S. B. Fazio, et al. ACCF/AHA/ACP 2009 Competence and Training Statement: A Curriculum on Prevention of Cardiovascular Disease: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association Circulation, September 29, 2009; 120(13): e100 - e126. [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Elder, A. H. Lichtenstein, A. G. Pittas, S. B. Roberts, P. J. Fuss, A. S. Greenberg, M. A. McCrory, T. J. Bouchard Jr., E. Saltzman, and M. C. Neale Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome J. Lipid Res., September 1, 2009; 50(9): 1917 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Sacco, S. H. Blanton, S. Slifer, A. Beecham, K. Glover, H. Gardener, L. Wang, E. Sabala, S.-H. H. Juo, and T. Rundek Heritability and Linkage Analysis for Carotid Intima-Media Thickness: The Family Study of Stroke Risk and Carotid Atherosclerosis Stroke, July 1, 2009; 40(7): 2307 - 2312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Doria, J. Wojcik, R. Xu, E. V. Gervino, T. H. Hauser, M. T. Johnstone, D. Nolan, F. B. Hu, and J. H. Warram Interaction Between Poor Glycemic Control and 9p21 Locus on Risk of Coronary Artery Disease in Type 2 Diabetes JAMA, November 26, 2008; 300(20): 2389 - 2397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Y. Chan, F. Andreotti, and R. C. Becker Hypercoagulable States in Cardiovascular Disease Circulation, November 25, 2008; 118(22): 2286 - 2297. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhou, X. Zhang, M. He, L. Cheng, Y. Chen, F. B. Hu, and T. Wu Associations Between Single Nucleotide Polymorphisms on Chromosome 9p21 and Risk of Coronary Heart Disease in Chinese Han Population Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 2085 - 2089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dietrich, M. Jimenez, E. A. Krall Kaye, P. S. Vokonas, and R. I. Garcia Age-Dependent Associations Between Chronic Periodontitis/Edentulism and Risk of Coronary Heart Disease Circulation, April 1, 2008; 117(13): 1668 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sanz, P. R. Moreno, and V. Fuster The year in atherothrombosis. J. Am. Coll. Cardiol., March 4, 2008; 51(9): 944 - 955. [Full Text] [PDF]
|
|
|
|
 |
|
 A J Turley, V Chen, and J A Hall Simultaneous presentation of coronary heart disease in identical twins Postgrad. Med. J., February 1, 2008; 84(988): 100 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. A. Iakoubova, M. S. Sabatine, C. M. Rowland, C. H. Tong, J. J. Catanese, K. Ranade, K. L. Simonsen, T. G. Kirchgessner, C. P. Cannon, J. J. Devlin, et al. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. J. Am. Coll. Cardiol., January 29, 2008; 51(4): 449 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Kuller Is Phenomenology the Best Approach to Health Research? Am. J. Epidemiol., November 15, 2007; 166(10): 1109 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Cambien and L. Tiret Genetics of Cardiovascular Diseases: From Single Mutations to the Whole Genome Circulation, October 9, 2007; 116(15): 1714 - 1724. [Full Text] [PDF]
|
|
|
|
|
|
J. W. Knowles, T. L. Assimes, J. Li, T. Quertermous, and J. P. Cooke Genetic Susceptibility to Peripheral Arterial Disease: A Dark Corner in Vascular Biology Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2068 - 2078. [Abstract] [Full Text] [PDF]
|
|